Shelley B. Thunen, Chief Financial Officer at RxSight, Inc. (RXST), sold 20,000 shares at $54.95 ($1.1M) on 2024-03-01, disclosed to the SEC on 2024-03-05.
Scheduled sale ($1.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.95 | 1,166 | $64K | 5.7% |
| 2 | $54.95 | 1,166 | $64K | 5.7% |
| 3 | $56.38 | 6,361 | $359K | 31.8% |
| 4 | $56.38 | 6,361 | $359K | 31.8% |
| 5 | $57.03 | 2,473 | $141K | 12.5% |
| 6 | $57.03 | 2,473 |
| $141K |
| 12.5% |
| Total | $56.37 avg | 20,000 | $1.1M | 100% |
| Filing → |
| RXST | SELL | 2024-05-02 | $1.0M | — | Filing → |
| RXST | SELL | 2024-04-02 | $1.9M | — | Filing → |
| RXST | SELL | 2024-02-07 | $2.4M | — | Filing → |